National News
NAFDAC halts Artemether/Lumefantrine registration

The National Agency for Food and Drug Administration and Control (NAFDAC) has halted the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
The announcement was made in a public alert No. 01/2025, released on the agency’s website yesterday.
NAFDAC explained that the decision was made due to the instability of the reconstituted formulations, which could lead to a loss of efficacy over time.
According NAFDAC, the suspension applies to all locally manufactured and imported Multi-Dose Artemether/Lumefantrine dry powder for oral use.
“NAFDAC will no longer accept new applications, renewals, or variations for this product.”
According to the Agency, stability studies revealed that reconstituted Artemether/Lumefantrine oral suspension becomes unstable after mixing, leading to a loss
Ifeoma Nwovu
-
News16 hours ago
Kogi Government vows justice for slain photojournalist Ayo Aiyepeku
-
News16 hours ago
Malaria kills nine Nigerians every hour — Society for Family Health raises alarm
-
Sports2 days ago
Super Falcons beats Morocco to clinch 10th WAFCON title
-
News16 hours ago
Dangote applauds Tinubu’s economic policies, commends Crude-For-Naira Initiative
-
Sports16 hours ago
England defeats Spain on penalties to win 2025 Women’s Euro tittle
-
Metro16 hours ago
Troops kill 45 bandits in fierce gun battle in Niger State
-
World News16 hours ago
Trump, EU reach tariff deal to avoid transatlantic trade war
-
Feature4 hours ago
FG Launches Project 365 to Tackle Hepatitis